PolyPeptide Group AG - ESG Rating & Company Profile powered by AI
This analysis of PolyPeptide Group AG incorporates data points from across the internet and also from available documents by PolyPeptide Group AG. Alternative companies in the scoring peer group for PolyPeptide Group AG are displayed. This report of PolyPeptide Group AG was prepared by All Street Sevva using leading NLP.
PolyPeptide Group AG in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.8; made up of an environmental score of 2.7, social score of 3.4 and governance score of 5.3.
3.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1089 | Zymeworks Inc | 3.9 | Medium |
| 1089 | bluebird bio Inc | 3.9 | Medium |
| 1112 | PolyPeptide Group AG | 3.8 | Medium |
| 1112 | AcelRx Pharmaceuticals Inc | 3.8 | Medium |
| 1112 | Arcus Biosciences Inc | 3.8 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does PolyPeptide Group AG have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes PolyPeptide Group AG disclose current and historical energy intensity?
Sign up for free to unlockDoes PolyPeptide Group AG report the average age of the workforce?
Sign up for free to unlockDoes PolyPeptide Group AG reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes PolyPeptide Group AG disclose its ethnicity pay gap?
Sign up for free to unlockDoes PolyPeptide Group AG disclose cybersecurity risks?
Sign up for free to unlockDoes PolyPeptide Group AG offer flexible work?
Sign up for free to unlockDoes PolyPeptide Group AG have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes PolyPeptide Group AG disclose the number of employees in R&D functions?
Sign up for free to unlockDoes PolyPeptide Group AG conduct supply chain audits?
Sign up for free to unlockDoes PolyPeptide Group AG disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes PolyPeptide Group AG conduct 360 degree staff reviews?
Sign up for free to unlockDoes PolyPeptide Group AG disclose the individual responsible for D&I?
Sign up for free to unlockDoes PolyPeptide Group AG disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes PolyPeptide Group AG disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes PolyPeptide Group AG disclose water use targets?
Sign up for free to unlockDoes PolyPeptide Group AG have careers partnerships with academic institutions?
Sign up for free to unlockDid PolyPeptide Group AG have a product recall in the last two years?
Sign up for free to unlockDoes PolyPeptide Group AG disclose incidents of discrimination?
Sign up for free to unlockDoes PolyPeptide Group AG allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas PolyPeptide Group AG issued a profit warning in the past 24 months?
Sign up for free to unlockDoes PolyPeptide Group AG disclose parental leave metrics?
Sign up for free to unlockDoes PolyPeptide Group AG disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes PolyPeptide Group AG disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes PolyPeptide Group AG disclose the pay ratio of women to men?
Sign up for free to unlockDoes PolyPeptide Group AG support suppliers with sustainability related research and development?
Sign up for free to unlockDoes PolyPeptide Group AG disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes PolyPeptide Group AG reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs PolyPeptide Group AG involved in embryonic stem cell research?
Sign up for free to unlockDoes PolyPeptide Group AG disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes PolyPeptide Group AG disclose its waste policy?
Sign up for free to unlockDoes PolyPeptide Group AG report according to TCFD requirements?
Sign up for free to unlockDoes PolyPeptide Group AG disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes PolyPeptide Group AG disclose energy use targets?
Sign up for free to unlockDoes PolyPeptide Group AG disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes PolyPeptide Group AG have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for PolyPeptide Group AG
These potential risks are based on the size, segment and geographies of the company.
PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products. It engages in manufacturing custom research grade peptides; and developing neoantigen peptide to support personalized cancer therapies. The company is also involved in manufacturing peptides for commercially approved peptide therapeutics. In addition, it manufactures peptide-based generics for human and veterinary markets; and cosmetic peptides. Further, the company offers regulatory affair support services. The company was founded in 1952 and is headquartered in Zug, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.